Hyperacidity, GERD, and ulcers:

Indications for: PAMINE

Adjunctive therapy in peptic ulcer.

Adult Dosage:

Initially 2.5mg 30min before meals and 2.5–5mg at bedtime; may increase as tolerated. Severe symptoms: may start at 5mg 30min before meals and at bedtime.

Children Dosage:

Not established.

PAMINE Contraindications:

Glaucoma. Obstructive uropathy (eg, bladder neck obstruction due to prostatic hypertrophy). GI obstruction (eg, pyloroduodenal stenosis). Paralytic ileus. Intestinal atony in elderly or debilitated. Unstable cardiovascular status in acute hemorrhage. Severe ulcerative colitis. Toxic megacolon complicating ulcerative colitis. Myasthenia gravis.

PAMINE Warnings/Precautions:

Ileostomy or colostomy. Autonomic neuropathy. Hepatic or renal disease. Ulcerative colitis. Hyperthyroidism. Coronary heart disease. CHF. Tachyrhythmia. Tachycardia. Hypertension. Prostatic hypertrophy. Large doses may suppress intestinal motility or aggravate toxic megacolon. Follow-up with upper GI contrast radiology or endoscopy during treatment. Obtain stool tests, hemoglobin, and hematocrit to rule out ulcer bleeding. High environmental temperature. Elderly. Pregnancy (Cat.C). Nursing mothers.

See Also:

PAMINE Classification:


PAMINE Interactions:

Additive anticholinergic effects with concomitant antipsychotics, tricyclic antidepressants, and other anticholinergic drugs. Concomitant antacids may interfere with absorption.

Adverse Reactions:

Tachycardia, palpitation, anaphylaxis, headache, nervousness, drowsiness, dizziness, blurred vision, pupil dilation, loss of taste, urinary hesitancy/retention, nausea, vomiting, constipation, decreased sweating, urticaria, xerostomia, weakness, insomnia, impotence, lactation suppression.

How Supplied:

Tabs—100; Forte—60 (5x12 blisters)